Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (4,573,354)	$ (4,732,214)
Adjustments to reconcile consolidated net loss to net cash flows from operating activities
Depreciation	3,683,815	3,381,249
Amortization	890,348	1,325,574
Loan cost amortization	106,882	107,595
Mandatorily redeemable preferred stock issuance cost and discount amortization	243,054	222,881
Above (below) market lease amortization, net	(275,107)	(226,721)
Bad debt expense	63,282	46,932
Share-based compensation		483,100
Impairment of assets held for sale	0	175,671
Loss on impairment	90,221	36,670
Loss on extinguishment of debt		389,207
Loss on disposal of investment property		421,096
Changes in assets and liabilities
Rent and other receivables, net	46,534	16,775
Unbilled rent	(100,010)	(149,831)
Other assets	31,371	(194,173)
Accounts payable and accrued liabilities	(103,023)	(109,185)
Net cash flows from operating activities	104,013	1,194,626
CASH FLOWS FROM INVESTING ACTIVITIES
Investment property acquisitions		(10,279,714)
Capital expenditures	(1,483,117)	(1,019,304)
Cash received from disposal of investment properties		1,979,837
Net cash flows from investing activities	(1,483,117)	(9,319,181)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividends and distributions paid	(383,665)	(1,309,180)
Cash paid for lender fees associated with Clemson Best Western sale		(84,900)
Proceeds from line of credit, short term	1,000,000
Proceeds from mortgages payable, net		18,477,304
Repayment of mortgages payable	(1,085,480)	(11,932,137)
Proceeds from sales of common stock, net of capitalized offering costs		1,538,887
Repurchases of common stock, including costs and fees		(286,543)
Retire fractional shares resulting from reverse stock split	(4,999)
Net cash flows from financing activities	(474,144)	6,403,431
DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	(1,853,248)	(1,721,124)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period	5,662,853	7,383,977
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period	$ 3,809,605	$ 5,662,853